Comprehensive Study Guide: Pain & Alterations in Comfort

Definition and Overview of Pain

• Pain is defined by the International Association for the Study of Pain (IASP) as: "an unpleasant sensory and emotional experience associated with actual or potential tissue damage…"

• Self-report is recognized as the most valid and reliable means of pain assessment.

• Pain serves a physiological purpose as a protective mechanism that alerts the body that harm or injury is occurring.

• Unnecessary suffering should be prevented through appropriate pain management strategies.

Physiology of Nociception

• Nociception is the neural process of encoding noxious stimuli. The four sequential processes include:

  • Transduction:

  • Noxious mechanical, thermal, or chemical stimuli cause cell damage and trigger the release of sensitizing chemicals, including:

    • Prostaglandins

    • Bradykinin

    • Serotonin

    • Substance P

    • Histamine

  • These substances activate peripheral nociceptors and convert the noxious stimulus into an electrical action potential.

  • Transmission:

  • The action potential propagates along nerve fibers through three main stages:

    1. From the site of injury to the dorsal horn of the spinal cord.

    2. From the spinal cord ascending to the brainstem and thalamus.

    3. From the thalamus to the cerebral cortex for sensory processing.

  • Perception:

  • The conscious sensory and emotional experience of pain occurs within the cerebral cortex.

  • Modulation:

  • Neurons originating in the brainstem descend down to the spinal cord and release inhibitory neurochemicals (such as endogenous opioids) to suppress nociceptive impulses.

Dimensions of Pain

• Each individual conceptualizes and experiences pain in a unique, multidimensional manner across five distinct dimensions:

  • Physiologic:

  • Anatomic, structural, and genetic components underlying pain perception.

  • Affective:

  • Emotional responses tied to pain, such as anger, fear, and anxiety.

  • Behavioral:

  • Observable actions used to express or cope with pain, including grimacing, irritability, withdrawal, or nonverbal behaviors (e.g., physical agitation or hitting in patients with dementia).

  • Cognitive:

  • Personal beliefs, attitudes, expectations, and understanding of pain.

  • Sociocultural:

  • Age and gender factors influencing nociceptive processing, neurotransmitter responses, drug metabolism, and declining kidney function in older adults.

  • Family dynamics and caregiver support systems influencing coping mechanisms and the effectiveness of non-pharmacologic interventions.

Classifications of Pain

Acute Pain vs. Chronic Pain

• Acute Pain:

  • Onset: Sudden.

  • Duration: $< 3\text{ months}$.

  • Severity: Mild to severe.

  • Cause: Identifiable cause (e.g., surgical incision, falling down stairs, acute headache).

  • Course: Decreases over time as tissue heals.

  • Typical Behaviors: Symptoms associated with Sympathetic Nervous System (SNS) activation (fight-or-flight response), such as tachycardia, hypertension, and diaphoresis.

  • Goals of Treatment: Achieve pain control and minimize side effects of treatment.

• Chronic Pain:

  • Onset: Gradual onset.

  • Duration: $> 3\text{ months}$.

  • Severity: Mild to severe.

  • Cause: May not be fully known or identifiable (e.g., L4-L5 herniated disc that does not clearly correlate with diagnostic findings).

  • Course: Wanes and waxes over time, persistent without full resolution.

  • Typical Behaviors: Flat affect, social withdrawal, absence of vital sign changes (body adapts/compensates to a new baseline), depression, anxiety, and agitation.

  • Goals of Treatment: Control pain, enhance overall quality of life, maintain function in activities of daily living (ADLs), and minimize side effects of treatment.

• Breakthrough Pain:

  • Transient flare-up of moderate-to-severe pain that occurs above a patient's baseline controlled pain level.

Nociceptive Pain vs. Neuropathic Pain

• Nociceptive Pain:

  • Represents normal physiological processing of noxious stimuli.

  • Responds well to over-the-counter (OTC) analgesics and opioids.

  • Somatic Pain:

  • Superficial Somatic: Involves skin and subcutaneous tissue; described as sharp, burning, or prickly.

  • Deep Somatic: Involves bone, joints, muscle, or deep tissue; described as aching or throbbing.

  • Visceral Pain:

  • Arises from internal organs and membrane linings (e.g., pancreatitis, inflammatory bowel disease / IBD).

  • Triggered by inflammation, ischemia, organ stretching, or cell death.

  • Described as deep, cramping, and poorly localized.

• Neuropathic Pain:

  • Caused by damage to peripheral nerves or structural components of the Central Nervous System (CNS).

  • Characteristics: Numbing, hot, burning, shooting, or electric shock-like sensations.

  • Onset/Course: Sudden, intense, short-lived, or lingering.

  • Typical Conditions: Phantom limb pain, diabetic neuropathy, multiple sclerosis (MS).

  • Management: Responds primary to adjuvant medications such as antidepressants and antiseizure drugs.

Negative Physiological Consequences of Unrelieved Acute Pain

• Cardiovascular System:

  • Responses: $\uparrow$ Cardiac output, $\uparrow$ Coagulation, $\uparrow$ Heart rate, $\uparrow$ Myocardial $O_2$ consumption, $\uparrow$ Peripheral vascular resistance.

  • Consequences: Deep vein thrombosis (DVT), hypertension, myocardial infarction, unstable angina.

• Endocrine and Metabolic System:

  • Responses: $\uparrow$ Adrenocorticotropic hormone (ACTH), $\uparrow$ Aldosterone, $\uparrow$ Antidiuretic hormone (ADH), $\uparrow$ Cortisol, $\uparrow$ Epinephrine and norepinephrine, gluconeogenesis, glycogenolysis, $\downarrow$ Insulin, muscle protein catabolism.

  • Consequences: $\uparrow$ Blood pressure, fluid overload, $\uparrow$ Heart rate, hyperglycemia, $\uparrow$ Respiratory rate, shock, urinary retention, $\downarrow$ Urine output, weight loss from elevated catabolism.

• Gastrointestinal System:

  • Responses: $\downarrow$ Gastric and intestinal motility.

  • Consequences: Anorexia, constipation, bowel obstruction, paralytic ileus.

• Immunologic System:

  • Responses: $\downarrow$ Immune response.

  • Consequences: Increased vulnerability to infection.

• Musculoskeletal System:

  • Responses: Impaired muscle function, muscle spasm.

  • Consequences: Immobility, weakness, and fatigue.

• Neurologic System:

  • Responses: Impaired cognitive function.

  • Consequences: Confusion, impaired ability to think, reason, and make decisions.

• Renal and Urologic System:

  • Responses: $\downarrow$ Urine output, urinary retention.

  • Consequences: Electrolyte imbalances, fluid volume imbalances.

• Respiratory System:

  • Responses: $\downarrow$ Cough with sputum retention, hypoxemia, $\downarrow$ Tidal volume.

  • Consequences: Atelectasis, pneumonia.

Pain Assessment Tools and Intensity Scales

Assessment Goals and Approach

• Describe the patient's subjective pain experience to implement appropriate management.

• Identify patient-centered functional goals (tolerable pain level, maintaining quality of life, performing ADLs).

• Utilize a multidimensional assessment strategy involving direct patient interviews, physical examination, diagnostic tests, and precise documentation.

0-10 Numeric Pain Intensity Scale

• Best For: Alert and oriented $\times 3$, verbal patients aged $> 8\text{ years}$.

• Pros: Objective, quantifiable, and easily understood across clinical environments.

• Cons: Patients may misinterpret the scale; requires patient education to obtain accurate data.

Wong-Baker FACES Pain Rating Scale

• Scale Increments: 0 (NO HURT), 2 (HURTS LITTLE BIT), 4 (HURTS LITTLE MORE), 6 (HURTS EVEN MORE), 8 (HURTS WHOLE LOT), 10 (HURTS WORST).

• Best For: Children aged $< 8\text{ years}$, patients with cognitive impairments, or visual communication needs.

• Pros: Provides visual objective data.

• Cons: Difficult to visualize subtle changes or trends; requires emotional intelligence to interpret facial expressions accurately.

FLACC Behavioral Scale

• Best For: Nonverbal adults and pediatric patients unable to self-report.

• Categories (Scored 0 to 2 each; Total Score 0 to 10):

  • Face:

  • 0: No particular expression or smile.

  • 1: Occasional grimace or frown, withdrawn, disinterested.

  • 2: Frequent to constant frown, quivering chin, clenched jaw.

  • Legs:

  • 0: Normal position or relaxed.

  • 1: Uneasy, restless, tense.

  • 2: Kicking or legs drawn up.

  • Activity:

  • 0: Lying quietly, normal position, moves easily.

  • 1: Squirming, shifting back and forth, tense.

  • 2: Arched, rigid, or jerking.

  • Cry:

  • 0: No cry (awake or asleep).

  • 1: Moans or whimpers; occasional complaint.

  • 2: Crying steadily, screams or sobs, frequent complaints.

  • Consolability:

  • 0: Content, relaxed.

  • 1: Reassured by occasional touching, hugging, or being talked to; distractible.

  • 2: Difficult to console or comfort.

Neonatal Infant Pain Scale (NIPS)

• Best For: Infants from birth to $1\text{ year}$.

• Pros: Objective behavior-based scale validated in neonates.

• Cons: Lacks self-report; difficult to differentiate pain from general agitation.

• Scoring: Maximum score of $7$ points; pain is indicated by a score \ge 4$.\n - **Facial Expression:** 0 = Relaxed, 1 = Contracted.\n - **Cry:** 0 = Absent, 1 = Mumbling, 2 = Vigorous.\n - **Breathing:** 0 = Relaxed, 1 = Different than basal.\n - **Arms:** 0 = Relaxed, 1 = Flexed/stretched.\n - **Legs:** 0 = Relaxed, 1 = Flexed/stretched.\n - **Alertness:** 0 = Sleeping/calm, 1 = Uncomfortable.\n\n## Richmond Agitation and Sedation Scale (RASS)\n\n\n\n- Evaluates level of consciousness and sedation, essential for safe opioid administration:\n - **+4 Combative:** Violent, immediate danger to staff.\n - **+3 Very Agitated:** Pulls or removes tube(s) or catheter(s); aggressive.\n - **+2 Agitated:** Frequent non-purposeful movement, fights ventilator.\n - **+1 Restless:** Anxious, apprehensive but movements not aggressive or vigorous.\n - **0 Alert & calm.**\n - **-1 Drowsy:** Not fully alert, but sustained awakening to voice (eye opening and contact \ge 10\text{ sec}).\n - **-2 Light sedation:** Briefly awakens to voice (eye opening and contact < 10\text{ sec}).\n - **-3 Moderate sedation:** Movement or eye-opening to voice (no eye contact).\n - **-4 Deep sedation:** No response to voice, but movement or eye opening to physical stimulation.\n - **-5 Unarousable:** No response to voice or physical stimulation.\n\n# Pain Management and Pharmacotherapy\n\n## Administration Principles\n- **Scheduling:**\n - Proactive scheduling is superior to reactive administration.\n - Waking patients for scheduled analgesics prevents breakthrough severe pain.\n - Discuss timing and risks of undertreatment with the patient.\n- **Titration:**\n - Use the smallest dose available to achieve adequate pain control.\n - Ensure safety by verifying time of last dose and confirming tolerance without toxic side effects.\n- **Routes of Administration:**\n - *Oral:* Standard tablets/liquids.\n - *Sublingual:* E.g., nitroglycerin for angina.\n - *Transmucosal/Buccal:* E.g., fentanyl (rapid onset < 10\text{ minutes}, used in hospice).\n - *Intranasal:* E.g., naloxone (Narcan).\n - *Rectal:* Used when oral route is unavailable or patient cannot swallow.\n - *Transdermal:* Patches (e.g., lidocaine for local pain, fentanyl for systemic pain); never remove without following medical guidelines; lower risk of side effects.\n - *Parenteral:* IV, IM, Subcutaneous. IV offers the fastest onset (indicated post-op, e.g., bowel resection, NG tube placement).\n - *Intraspinal:* Epidural or intrathecal catheters and surgically implanted pumps (bolus or continuous infusion over 30-90 days).\n\n## Opioid Monitoring and Safety Considerations\n- **Pre-Administration Nursing Assessments:**\n - *Respiratory Status:* Assess rate and depth. Hold or question dose if respiratory rate is 8\text{--}10\text{ breaths/min} or lower.\n - *Blood Pressure:* Assess baseline. Hold if BP < 90/60\text{ mmHg}.\n - *Sedation Level:* Assess using RASS scale. A score of -2 or lower indicates unsafe sedation.\n- **Opioid Side Effects:**\n - *Common:* Constipation, nausea/vomiting, sedation, respiratory depression, pruritus (itching).\n - *Less Common:* Urinary retention, hallucinations, confusion.\n- **Clinical Risk Factors:**\n - Start a prophylactic bowel regimen early to prevent opioid-induced constipation.\n - High-risk populations for respiratory depression: Patients aged > 65\text{ years}, sleep apnea, underlying heart/lung disease, obesity, smoking history, or concurrent CNS depressant use.\n - Peak sedation risk occurs 4\text{ hours} after PACU discharge.\n\n## Patient-Controlled Analgesia (PCA) Mathematics\n- **Sample Calculation:**\n - *Settings:* Hydromorphone (0.2\,mg/mL)\n - *Basal Dose:* 0.4\,mg/hr (continuous)\n - *Demand Dose:* 0.2\,mg\n - *Lockout Interval:* 10\text{ minutes}\n - *Question:* What is the total mg of hydromorphone the patient receives in 8\text{ hours} if no demand doses are requested?\n - *Calculation:* \n    \text{Total Basal Dose} = 0.4\,mg/hr \times 8\,hrs = 3.2\,mg\n\n# Opioid Antagonists and Overdose Management\n\n\n\n- **Mechanism of Action:** Naloxone (Narcan) competes with opioids at the same neuroreceptor sites, rapidly reversing opioid effects.\n- **Indications:** Excessive sedation, unresponsiveness, severe bradypnea/hypoventilation, severe hypotension.\n- **Nursing Considerations:**\n - Naloxone has a shorter half-life than most opioids; the nurse must **stay with the patient** as repeated doses may be required when naloxone wears off.\n - Rapid reversal can trigger acute withdrawal and patient agitation.\n - Precipitates severe pain crisis in chronic pain patients.\n- **Routes & Dosages:**\n - Intranasal spray (e.g., 4\,mg$per$0.1\,mL unit dose).\n - Parenteral: IV, IM, or Subcutaneous (e.g., 0.4\,mg/mL$or$2\,mg/2\,mL prefilled syringe).\n\n## Practice Case Scenario\n- **Case Description:** A 61$-year-old patient returns to the unit following spinal surgery with a PCA pump. Her spouse reports she is groggy, difficult to arouse, and the$O_2$saturation monitor became disconnected. Upon reconnection,$O_2$saturation is$89\%$and respiratory rate is$8\text{--}10\text{ breaths/min}.\n- **Priority Nursing Actions:**\n 1. Stop the PCA pump continuous/demand administration immediately.\n 2. Apply supplemental oxygen.\n 3. Administer naloxone (Narcan).\n 4. Remain at the bedside and continuously monitor respiratory rate, SpO_2$$, and level of consciousness.

Non-Pharmacologic Pain Interventions

• Massage

• Exercise

• Transcutaneous Electrical Nerve Stimulation (TENS)

• Acupuncture

• Hypnosis and relaxation techniques

• Heat therapy

• Cold therapy

• Distraction

Evaluation and Undertreatment of Pain

Pain Evaluation Guidelines

• Reassess pain at appropriate intervals guided by:

  • Pain severity

  • Physical and psychosocial condition

  • Specific intervention performed

  • Presence of adverse effects

  • Institutional policy

Factors Contributing to Nursing Undertreatment of Pain

• Misconceptions or exaggerated fear regarding patient addiction or tolerance.

• Fear of inducing severe respiratory depression or side effects.

• Inadequate pain assessment skills or over-reliance on stable vital signs.

• Insufficient knowledge regarding pain pharmacology and dose titration.